tradingkey.logo

GE Healthcare Technologies Inc

GEHC
查看詳細走勢圖
83.960USD
0.000
收盤 12/15, 16:00美東報價延遲15分鐘
38.24B總市值
17.30本益比TTM

GE Healthcare Technologies Inc

83.960
0.000
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

+1.05%

1月

+14.78%

6月

+16.21%

今年開始到現在

+7.39%

1年

+3.53%

查看詳細走勢圖

操作建議

GE Healthcare Technologies Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名24/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價88.47。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

GE Healthcare Technologies Inc評分

相關信息

行業排名
24 / 208
全市場排名
90 / 4592
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 22 分析師
買入
評級
88.468
目標均價
+6.47%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

GE Healthcare Technologies Inc亮點

亮點風險
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
估值低估
公司最新PE估值17.30,處於3年歷史低位
肯·費雪持倉
明星投資者肯·費雪持倉,最新持倉4.55K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.10

GE Healthcare Technologies Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

GE Healthcare Technologies Inc簡介

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
公司代碼GEHC
公司GE Healthcare Technologies Inc
CEOBankes (Jeannette)
網址https://www.gehealthcare.com

常見問題

GE Healthcare Technologies Inc(GEHC)的當前股價是多少?

GE Healthcare Technologies Inc(GEHC)的當前股價是 83.960。

GE Healthcare Technologies Inc 的股票代碼是什麼?

GE Healthcare Technologies Inc的股票代碼是GEHC。

GE Healthcare Technologies Inc股票的52週最高點是多少?

GE Healthcare Technologies Inc股票的52週最高點是94.800。

GE Healthcare Technologies Inc股票的52週最低點是多少?

GE Healthcare Technologies Inc股票的52週最低點是57.650。

GE Healthcare Technologies Inc的市值是多少?

GE Healthcare Technologies Inc的市值是38.24B。

GE Healthcare Technologies Inc的淨利潤是多少?

GE Healthcare Technologies Inc的淨利潤為1.99B。

現在GE Healthcare Technologies Inc(GEHC)的股票是買入、持有還是賣出?

根據分析師評級,GE Healthcare Technologies Inc(GEHC)的總體評級為買入,目標價格為88.468。

GE Healthcare Technologies Inc(GEHC)股票的每股收益(EPS TTM)是多少

GE Healthcare Technologies Inc(GEHC)股票的每股收益(EPS TTM)是4.852。
KeyAI